Effect of HDAC inhibitors on neuroprotection and neurite outgrowth in primary rat cortical neurons following ischemic insult

Neurochemical Research

Volumn 38, Issue 9, 2013, Pages 1921-1934

  Hasan, Mohammad Rakibul ^a   Kim, Ji Hye ^a   Kim, Youn Jung ^c   Kwon, Kyoung Ja ^a   Shin, Chan Young ^a   Kim, Hahn Young ^a   Han, Seol Heui ^a   Choi, Dong Hee ^a,b   Lee, Jongmin ^a,b  

^a Konkuk University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Brain derived neurotrophic factor; HDAC inhibitors; Neurite outgrowth; Oxygen glucose deprivation; Primary cortical neurons

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; LACTATE DEHYDROGENASE; NEUROMODULIN; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPTOPHYSIN;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; CELL LEVEL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA CONFORMATION; DNA TRANSCRIPTION; EMBRYO; FEMALE; HISTONE ACETYLATION; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REOXYGENATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

RATTUS;

ANIMALS; BASE SEQUENCE; BRAIN-DERIVED NEUROTROPHIC FACTOR; DNA PRIMERS; FEMALE; HISTONE DEACETYLASE INHIBITORS; NEURITES; NEUROPROTECTIVE AGENTS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84881480358     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1098-9     Document Type: Article

References (34)

1. Langley B, Gensert JM, Beal MF, Ratan RR (2005) Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Curr Drug Targets CNS Neurol Disord 4(1):41-50
2. Xu WS, Parmigiani RB, Marks PA (2007) Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26(37):5541-5552
3. Hu E, Dul E, Sung CM, Chen Z, Kirkpatrick R, Zhang GF, Johanson K, Liu R, Lago A, Hofmann G, Macarron R, de los Frailes M, Perez P, Krawiec J, Winkler J, Jaye M (2003) Identification of novel isoform-selective inhibitors within class I histone deacetylases. J Pharmacol Exp Ther 307(2):720-728
4. Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH (2004) Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci USA 101(47):16659-16664
5. Di Daniel E, Mudge AW, Maycox PR (2005) Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons. Bipolar Disord 7(1):33-41
6. Hall AC, Brennan A, Goold RG, Cleverley K, Lucas FR, Gordon-Weeks PR, Salinas PC (2002) Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Mol Cell Neurosci 20(2):257-270
7. Hao Y, Creson T, Zhang L, Li P, Du F, Yuan P, Gould TD, Manji HK, Chen G (2004) Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J Neurosci 24(29):6590-6599
8. Yamauchi J, Miyamoto Y, Murabe M, Fujiwara Y, Sanbe A, Fujita Y, Murase S, Tanoue A (2007) Gadd45a, the gene induced by the mood stabilizer valproic acid, regulates neurite outgrowth through JNK and the substrate paxillin in N1E - 115 neuroblastoma cells. Exp Cell Res 313(9):1886-1896
9. Yuan PX, Huang LD, Jiang YM, Gutkind JS, Manji HK, Chen G (2001) The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J Biol Chem 276(34):31674-31683
10. Gobbi G, Janiri L (2006) Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex. Psychopharmacology 185(2):255-262
11. Li X, Ketter TA, Frye MA (2002) Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? J Affect Disord 69(1-3):1-14
12. Cunningham MO, Woodhall GL, Jones RS (2003) Valproate modifies spontaneous excitation and inhibition at cortical synapses in vitro. Neuropharmacology 45(7):907-917
13. Zhang MM, Yu K, Xiao C, Ruan DY (2003) The influence of developmental periods of sodium valproate exposure on synaptic plasticity in the CA1 region of rat hippocampus. Neurosci Lett 351(3):165-168
14. Vecsey CG, Hawk JD, Lattal KM, Stein JM, Fabian SA, Attner MA, Cabrera SM, McDonough CB, Brindle PK, Abel T, Wood MA (2007) Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB: CBP-dependent transcriptional activation. J Neurosci 27(23):6128-6140
15. Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM (2009) The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 14(1):51-59
16. Bredy TW, Wu H, Crego C, Zellhoefer J, Sun YE, Barad M (2007) Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem 14(4):268-276
17. Jeong MR, Hashimoto R, Senatorov VV, Fujimaki K, Ren M, Lee MS, Chuang DM (2003) Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Lett 542(1-3):74-78
18. Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM (2007) Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 321(3):892-901
19. Wilot LC, Bernardi A, Frozza RL, Marques AL, Cimarosti H, Salbego C, Rocha E, Battastini AM (2007) Lithium and valproate protect hippocampal slices against ATP-induced cell death. Neurochem Res 32(9):1539-1546
20. Freidkin I, Herman M, Tobar A, Chagnac A, Ori Y, Korzets A, Gafter U (2010) Effects of histone deacetylase inhibitors on rat mesangial cells. Am J Physiol Renal Physiol 298(2):F426-F434
21. Eyal S, Lamb JG, Smith-Yockman M, Yagen B, Fibach E, Altschuler Y, White HS, Bialer M (2006) The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver. Br J Pharmacol 149(3):250-260
22. Hummel TR, Wagner L, Ahern C, Fouladi M, Reid JM, McGovern RM, Ames MM, Gilbertson RJ, Horton T, Ingle AM, Weigel B, Blaney SM (2013) A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a children's oncology group phase 1 consortium study. Pediatr Blood Cancer 60(3):390-395
23. Friday BB, Anderson SK, Buckner J, Yu C, Giannini C, Geoffroy F, Schwerkoske J, Mazurczak M, Gross H, Pajon E, Jaeckle K, Galanis E (2012) Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study. Neuro Oncol 14(2):215-221
24. Shein NA, Shohami E (2011) Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries. Mol Med 17(5-6):448-456
25. Leker RR, Shohami E, Constantini S (2002) Experimental models of head trauma. Acta Neurochir Suppl 83:49-54
26. Bramlett HM, Dietrich WD (2004) Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab 24(2):133-150
27. Lei Z, Ruan Y, Yang AN, Xu ZC (2006) NMDA receptor mediated dendritic plasticity in cortical cultures after oxygen-glucose deprivation. Neurosci Lett 407(3):224-229
28. Ay I, Sugimori H, Finklestein SP (2001) Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats. Brain Res Mol Brain Res 87(1):71-80
29. Dancause N, Barbay S, Frost SB, Plautz EJ, Chen D, Zoubina EV, Stowe AM, Nudo RJ (2005) Extensive cortical rewiring after brain injury. J Neurosci 25(44):10167-10179
30. Kim HJ, Leeds P, Chuang DM (2009) The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J Neurochem 110(4):1226-1240
31. Castro LM, Gallant M, Niles LP (2005) Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J Neurochem 95(5):1227-1236
32. Wu X, Chen PS, Dallas S, Wilson B, Block ML, Wang CC, Kinyamu H, Lu N, Gao X, Leng Y, Chuang DM, Zhang W, Lu RB, Hong JS (2008) Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol 11(8):1123-1134
33. Chang YC, Rapoport SI, Rao JS (2009) Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex. Neurochem Res 34(3):536-541
34. Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM (2004) Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 89(6):1358-1367